Table 1 Intracavernous and mean arterial pressure measurements following cavernous nerve electrostimulation.

From: Neuroprotective effect of docosahexaenoic acid nanoemulsion on erectile function in a rat model of bilateral cavernous nerve injury

Groups

Maximum ICP

∆ICP

AUC

∆ICP/MAP

Max ICP/MAP

Sham

105.92 ± 17.29*

87.04 ± 9.52*

4333.12 ± 948.81*

0.63 ± 0.10*

0.76 ± 0.08*

Vehicle only

40.63 ± 9.87

22.15 ± 8.69

653.91 ± 253.55

0.20 ± 0.09

0.35 ± 0.10

10 μg/Kg nano-DHA

67.93 ± 20.72**

49.43 ± 20.32*

2139.55 ± 1338.35

0.36 ± 0.13

0.48 ± 0.13

50 μg/Kg nano-DHA

94.05 ± 12.22*

71.31 ± 17.77*

3068.14 ± 1211.60*

0.50 ± 0.20*

0.64 ± 0.18*

250 μg/Kg nano-DHA

73.64 ± 10.08*

56.23 ± 12.80*

2405 ± 633.35*

0.44 ± 0.09*

0.59 ± 0.06*

  1. AUC, area under the curve; ICP, intracavernous pressure; MAP, mean arterial pressure.
  2. ∆ICP = Max ICP − Min ICP.
  3. *p < 0.05 versus vehicle only group.
  4. **p < 0.05 versus 50 μg/kg nano-DHA group.
Back to article page